TOX3 and metastatic malignant neoplasm in the lymph nodes: As shown in Fig 7A and 7B, the increased TOX3, WDR5, and ABCG2 expression was respectively detected in the majority of metastatic CRCs as compared with those with no lymph node metastasis.